Search research articles
Contact Us
Filters
Showing results (221-230 of 274) with videos related to
Page
of 28
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 15, 2025
Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec-9 and Suppresses Macrophage Phagocytosis
Ying Wu, Yuyu You, Tingsong Jiang, et al.
Journal of Medicinal Chemistry
|
April 6, 2026
Multifunctional RNA G-Quadruplex Ligand for Integrated Photodynamic Therapy and Oncoprotein Translation Inhibition in Cancer Cells
Wei Long, Bo-Xin Zheng, Ya-Kun Wang, et al.
Angewandte Chemie (International Ed. in English)
|
April 27, 2023
Protein-Targeted Glycan Editing on Living Cells Disrupts KRAS Signaling
Yiran Li, Fan Huo, Liusheng Chen, et al.
The Journal of Biological Chemistry
|
January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
The Oncologist
|
May 1, 2015
Phase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment
Ru Jia, Yan Wang, Xiao-Yang Mao, et al.
Nature Communications
|
June 7, 2020
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
Agnieshka M Agasing, Qi Wu, Bhuwan Khatri, et al.
Journal of Neuroimmunology
|
March 25, 2025
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Advances in Therapy
|
November 21, 2024
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients
Yang Mao-Draayer, Amit Bar-Or, Konstantin Balashov, et al.
EMBO Reports
|
July 12, 2023
MOV10 recruits DCP2 to decap human LINE-1 RNA by forming large cytoplasmic granules with phase separation properties
Qian Liu, Dongrong Yi, Jiwei Ding, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 274) with videos related to
Sort By:
Page
of 28
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 15, 2025
Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec-9 and Suppresses Macrophage Phagocytosis
Ying Wu, Yuyu You, Tingsong Jiang, et al.
Journal of Medicinal Chemistry
|
April 6, 2026
Multifunctional RNA G-Quadruplex Ligand for Integrated Photodynamic Therapy and Oncoprotein Translation Inhibition in Cancer Cells
Wei Long, Bo-Xin Zheng, Ya-Kun Wang, et al.
Angewandte Chemie (International Ed. in English)
|
April 27, 2023
Protein-Targeted Glycan Editing on Living Cells Disrupts KRAS Signaling
Yiran Li, Fan Huo, Liusheng Chen, et al.
The Journal of Biological Chemistry
|
January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
The Oncologist
|
May 1, 2015
Phase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment
Ru Jia, Yan Wang, Xiao-Yang Mao, et al.
Nature Communications
|
June 7, 2020
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
Agnieshka M Agasing, Qi Wu, Bhuwan Khatri, et al.
Journal of Neuroimmunology
|
March 25, 2025
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Advances in Therapy
|
November 21, 2024
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients
Yang Mao-Draayer, Amit Bar-Or, Konstantin Balashov, et al.
EMBO Reports
|
July 12, 2023
MOV10 recruits DCP2 to decap human LINE-1 RNA by forming large cytoplasmic granules with phase separation properties
Qian Liu, Dongrong Yi, Jiwei Ding, et al.
Page
of 28